Volume 38, No 3
Autumn 2020

  1. Emerging threats of antibiotics in the environment: what about the pharmaceutical industry?
    Véronique Mondain, Florence Lieutier-Colas

  2. A Multidisciplinary, French-speaking course on Antimicrobial Stewardship in Africa: the MUFASA Project
    Armel Poda, Abdoul-Salam Ouédraogo, Sylvain Godreuil, JeanBaptiste Guiard-Schmid, Xavier Lescure, Pierre Tattevin

  3. Bacteriophages: when history can save the future
    Fatima Allaw, Jean-Francois Jabbour, Souha S. Kanj

Volume 38, No 2
Summer 2020, COVID-19 special

  1. Creating a collaborative approach to antimicrobial stewardship education across the Gulf, Middle East, and North Africa (MENA): A case study from the British Society for Antimicrobial Chemotherapy (BSAC)
    Dilip Nathwani, Tracey Guise, Debbie Cockayne

  2. An update on e-Bug progress in France
    Pia Touboul,Virginie Lacroix Hugues, Brigitte Dunais

  3. Corona Virus in the Kingdom of Saudi Arabia
    Mushira Enani

Tales from the COVID-19 Frontline by Members of ISAC Executive Committee & APUA Board / Chapters

Volume 38, No 1
Winter 2020

  1. The key role of non-profit, non-governmental organisations in the fight against antibiotic resistance: the example of WAAAR
    Jean Carlet and Garance Upham

  2. International Centre for Antimicrobial Resistance Solutions (ICARS)
    Robert Skov, Ghada Zoubiane and Kåre Mølbak

  3. From bad to worse: emergence of extensively drug resistance Gram negative bacilli among Nigerian immunocompromised patients
    Ibrahim Yusuf

Stuart Levy Tribute Newsletter
November 2019
Volume 37, No 2
Summer 2019
Volume 37, No 1
Spring 2019
Volume 36, No 1
Spring 2018
"Looking at the Evidence for Short-term Antibiotic Therapy"
Volume 35, No. 2
Fall 2017
"Turning the Tide: Incentivizing Antibiotic Development and Stewardship"
Volume 35, No. 1
Spring 2017
"Antimicrobial Stewardship in Practice and in Theory"
Volume 34, No. 3
Winter 2016/2017
"Assessing MDR Pathogens in Humans, Pets and the Environment"
Volume 34, No. 2

Examples of articles focused on developing world issues include:

  • “Acute Respiratory Infections in Resource-Poor Countries.” Interviews with Keith Klugman of Emory University and Shamim Qazi of WHO (Vol. 24, No. 3, 2006).

  • “Comparing the Twin Epidemics of AMR and HIV.” Ken Mayer of Brown University (Vol. 23, No. 1, 2005).

  • “How is Multi-Resistant Tuberculosis Managed in Resource Poor Settings?” Jennifer J. Furin of Case Western Reserve University (Vol. 22, No. 4, 2004).

  • “Resistant Respiratory Infections Threaten Developing Countries.” Anita K.M. Zaidi of Aga Khan University (Vol. 21, No. 3, 2003).

  • “Special Challenges to the Study of AMR in Africa.” Iruke N. Okeke of APUA’s sub-Saharan Africa Chapter (Vol. 20, No. 4, 2002).

  • “Better Diagnostics- A Means for Selecting More Effective Antimicrobial Agents.” Interview with Mark Perkins, MD, Chief Scientific Officer for FIND (Vol. 25, No.1, 2007).

  • “Infection Control: A Potent Antimicrobial Resistance Containment Strategy.” (Vol. 26, No. 2 & 3, 2008).

Articles focused on U.S. and Public Policy include:

  • “Confronting the Need for New Antimicrobials.” Interview with Michael G. Kurilla, Associate Director for BioDefense Product Development, DMID, NIAID, NIH, DHHS (Vol. 24, No.2, 2006).

  • “Tapping the Power of Genomics for Drug Discovery.” Interview with Claire Fraser, President, the Institute for Genomic Research (Vol. 24, No.2, 2006).

  • “APUA Fields Antibiotic Use Questionnaire in U.S.” (Vol. 24, No.3, 2006).

  • “APUA Impacting Public Policy: FDA Urged to Reject Cefquinome in Agriculture.” (Vol. 25, No.1, 2007).


ISSN 2333-4363 (Online)
ISSN 1524-1424 (Print)